Compare Humana Inc (HUM) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Nvidia Corp — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Nvidia Corp trades at $218.15 (market cap $5.27T). The key difference: Nvidia Corp is far larger — about 113.8× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | NVDA | |
|---|---|---|
Market Cap | $46.31B | $5.27T |
Sector | Health | Technology |
52-Week High | $409.42 | $235.75 |
52-Week Low | $163.67 | $165.17 |
Enterprise Value | $53.67B | $5.20T |
Dividend Yield | 0.92% | 0.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
NVIDIA (NVDA) trades at $217.48, down 2.89% on the day, with strong fundamentals including a 55.84% net income margin and 114.29% ROE. The stock shows a bullish technical trend, supported by moving averages, and has consistently beaten earnings expectations. Recent news highlights AI-driven growth potential, though some articles caution about valuation and market rotation.
Outlook remains positive with a consensus price target of $325.86, implying significant upside. Key opportunities include leadership in AI chips and robust financials, while risks involve high valuation multiples, competition, and macroeconomic sensitivity. The stock presents a growth opportunity tempered by execution and market risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
